Batch number RGXBPC15710-2602-01 was tested and confirmed as follows: Purity: 99.1% (HPLC peptide screening) Identity by retention time: Confirmed (score: 0.999) Identity by mass spectrum: Confirmed (score: 993) Assay content: 14.64 mg per vial Endotoxins: /Eur
As of June 2026, cagrilintide is not FDA-approved in any form
Published certificates of analysis Our third-party certificates of analysis are published on our website no login required
Versatility : Often paired with peptides like TB-500 and BPC-157 in regeneration-focused research designs
Lancet 377:19291937 Creager MA, Olin JW, Belch JJ, Moneta GL, Henry TD, Rajagopalan S, Annex BH, Hiatt WR (2011) Effect of hypoxia-inducible factor-1alpha gene therapy on walking performance in patients with intermittent claudication
Its composition can adapt and change in response to the environment, and a favorable environment can lead to a more beneficial microbiome